Cargando…
Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis
Paradoxical psoriasis or psoriasiform lesion is an adverse effect, represented by the occurrence of a psoriasiform lesion or exacerbation of psoriasis caused by the drugs normally used for the management of psoriasis. In this article, we present the first case of a 45-year-old male patient with rheu...
Autores principales: | Erol, Kemal, Ertaş, Ragıp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Turkish League Against Rheumatism
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788646/ https://www.ncbi.nlm.nih.gov/pubmed/33458669 http://dx.doi.org/10.46497/ArchRheumatol.2020.7541 |
Ejemplares similares
-
Tofacitinib for the Treatment of Psoriasiform Dermatitis Caused by IL-17 Inhibitors: A Case Report
por: Luo, Nan, et al.
Publicado: (2023) -
Tofacitinib Citrate for Ulcerative Keratitis in a Patient with Rheumatoid Arthritis
por: Meadow, Philip B., et al.
Publicado: (2014) -
Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy
por: Koulouri, Vasiliki, et al.
Publicado: (2021) -
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis
por: Vacchi, Caterina, et al.
Publicado: (2021) -
Clinical Experience with Oral Tofacitinib in a Patient with Alopecia Areata Universalis and Rheumatoid Arthritis
por: Abe, Daniele Tiemi, et al.
Publicado: (2020)